Prostate Cancer Logo

Prostate Cancer UK – the official charity of the LMA - aims to reach millions of football supporters to raise awareness of the disease which now affects 1 in 8 men in the UK, with a death rate of 10,000 a year. 

Through the LMA partnership, the charity is asking managers and football legends to add their voice to their Men United campaign, by taking part in events and fundraising activities or by simply wearing the iconic Man of Men pin badge.

As well as raising awareness of the disease, the partnership will help to raise funds so that more men survive it and enjoy a better quality of life. 

Prostate Cancer UK is also the Official Charity Partner of The Football League - galvanising the football family and inspiring a movement for change in men’s health to win the battle against prostate cancer once and for all.  The Man of Men logo will feature in the squad number of every Football League player in the 2014/15 and 2015/16 seasons respectively. 

Supporters are encouraged to represent their club in the third annual charity challenge and cycle from London to Amsterdam in June 2015. And if that wasn’t enough clubs, fans and volunteers will combine at Men United match days across the country in March and April 2015. 

Prostate cancer is the most common cancer diagnosed in men in the UK. Over 40,000 men are diagnosed with prostate cancer every year. Every hour 1 man dies from prostate cancer. One in four black men in the UK will develop prostate cancer at some point in their lives. 

Prostate Cancer UK fights to help more men survive prostate cancer and enjoy a better quality of life. It funds research into causes and treatments and provides support and information. 

Men United v Prostate Cancer is the charity’s call for men to join together in a movement against the common enemy of prostate cancer. The aim is to build a united front of men against this disease. To get the message out about one of the UK’s biggest man killers, support men affected by it, and intensify the search for more reliable tests and treatments for the future. 

Prostate cancer